Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
CC transcript

MAXCYTE, INC. (MXCT) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/12/2023 4 Doerfler Douglas (President and CEO) has filed a Form 4 on MAXCYTE, INC.
Txns: Sold 445 shares @ $5.01, valued at $2.2k
Sold 12,798 shares @ $5.04, valued at $64.5k
Sold 16,757 shares @ $5.02, valued at $84.1k
Exercised 445 options to buy @ $0.04, valued at $17.8
Exercised 12,798 options to buy @ $0.04, valued at $511.9
Exercised 16,757 options to buy @ $0.04, valued at $670.3
06/28/2023 4 Johnston John Joseph (Director) has filed a Form 4 on MAXCYTE, INC.
Txns: Sold 7,529 shares @ $4.49, valued at $33.8k
Sold 7,471 shares @ $4.39, valued at $32.8k
Exercised 6,817 options to buy @ $0.983, valued at $6.7k
Exercised 712 options to buy @ $1.641, valued at $1.2k
Exercised 7,471 options to buy @ $1.641, valued at $12.3k
05/05/2023 4 Doerfler Douglas (President and CEO) has filed a Form 4 on MAXCYTE, INC.
Txns: Sold 16,149 shares @ $5.02, valued at $81.1k
Exercised 16,149 options to buy @ $0.04, valued at $646
04/04/2023 4 Ross Thomas M. (EVP, Global Sales & Marketing) has filed a Form 4 on MAXCYTE, INC.
Txns: Sold 2,607 shares @ $5, valued at $13k
Sold 100 shares @ $5.01, valued at $501
Sold 7,266 shares @ $5.03, valued at $36.5k
Exercised 2,607 options to buy @ $2.142, valued at $5.6k
Exercised 100 options to buy @ $2.142, valued at $214.2
Exercised 7,266 options to buy @ $2.142, valued at $15.6k
04/04/2023 4 Doerfler Douglas (President and CEO) has filed a Form 4 on MAXCYTE, INC.
Txns: Sold 2,607 shares @ $5, valued at $13k
Sold 100 shares @ $5.01, valued at $501
Sold 7,470 shares @ $5.03, valued at $37.6k
Exercised 2,607 options to buy @ $0.04, valued at $104.3
Exercised 100 options to buy @ $0.04, valued at $4
Exercised 7,470 options to buy @ $0.04, valued at $298.8
03/30/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/28/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/28/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
03/21/2023 4 Holtz Ron (CFO) has filed a Form 4 on MAXCYTE, INC.
Txns: Granted 120,000 options to buy @ $4.19, valued at $502.8k
03/21/2023 4 Hemrajani Rekha (Director) has filed a Form 4 on MAXCYTE, INC.
Txns: Granted 40,000 options to buy @ $4.19, valued at $167.6k
03/21/2023 4 Al-Wakeel Yasir B. (Director) has filed a Form 4 on MAXCYTE, INC.
Txns: Granted 40,000 options to buy @ $4.19, valued at $167.6k
03/21/2023 4 Masoud Maher (EVP and General Counsel) has filed a Form 4 on MAXCYTE, INC.
Txns: Granted 120,000 options to buy @ $4.19, valued at $502.8k
03/21/2023 4 Ross Thomas M. (EVP, Global Sales & Marketing) has filed a Form 4 on MAXCYTE, INC.
Txns: Granted 120,000 options to buy @ $4.19, valued at $502.8k
03/21/2023 4 Doerfler Douglas (President and CEO) has filed a Form 4 on MAXCYTE, INC.
Txns: Granted 400,000 options to buy @ $4.19, valued at $1.7M
03/21/2023 4 Sumen Cenk (Chief Scientific Officer) has filed a Form 4 on MAXCYTE, INC.
Txns: Granted 500,000 options to buy @ $5.7, valued at $2.9M
Granted 120,000 options to buy @ $4.19, valued at $502.8k
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2023 4 Doerfler Douglas (President and CEO) has filed a Form 4 on MAXCYTE, INC.
Txns: Sold 10,613 shares @ $5.13, valued at $54.4k
Sold 9,153 shares @ $5.07, valued at $46.4k
Sold 10,234 shares @ $5.04, valued at $51.6k
Exercised 10,613 options to buy @ $0.04, valued at $424.5
Exercised 9,153 options to buy @ $0.04, valued at $366.1
Exercised 10,234 options to buy @ $0.04, valued at $409.4
01/05/2023 4 Ross Thomas M. (EVP, Global Sales & Marketing) has filed a Form 4 on MAXCYTE, INC.
Txns: Sold 10,513 shares @ $5.13, valued at $53.9k
Sold 9,153 shares @ $5.07, valued at $46.4k
Sold 9,467 shares @ $5.04, valued at $47.7k
Exercised 10,513 options to buy @ $0.983, valued at $10.3k
Exercised 9,153 options to buy @ $0.983, valued at $9k
Exercised 9,467 options to buy @ $0.983, valued at $9.3k
12/06/2022 4 Ross Thomas M. (EVP, Global Sales & Marketing) has filed a Form 4 on MAXCYTE, INC.
Txns: Exercised 15,000 shares @ $1.08, valued at $16.2k
Sold 15,000 shares @ $6.02, valued at $90.3k
Exercised 14,133 shares @ $1.08, valued at $15.3k
Sold 14,133 shares @ $5.59, valued at $79k
Exercised 15,000 options to buy @ $0
Exercised 14,133 options to buy @ $0
12/01/2022 4 BALTHROP PATRICK J (Director) has filed a Form 4 on MAXCYTE, INC.
Txns: Granted 100,000 options to buy @ $5.99, valued at $599k
12/01/2022 3 BALTHROP PATRICK J (Director) has filed a Form 3 on MAXCYTE, INC.
11/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/12/2022 4 Ross Thomas M. (EVP, Global Sales & Marketing) has filed a Form 4 on MAXCYTE, INC.
Txns: Sold 24,851 shares @ $6.45, valued at $160.3k
Sold 4,282 shares @ $6.51, valued at $27.9k
Exercised 24,851 options to buy @ $0.84, valued at $20.9k
Exercised 4,282 options to buy @ $0.84, valued at $3.6k
10/05/2022 4 Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on MAXCYTE, INC.
Txns: Sold 735,786 shares @ $6.15, valued at $4.5M
07/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2022 4 DOUGLAS RICHARD (Director) has filed a Form 4 on MAXCYTE, INC.
Txns: Granted 26,900 options to buy @ $4.82, valued at $129.7k
07/08/2022 4 Brooke William W (Director) has filed a Form 4 on MAXCYTE, INC.
Txns: Granted 26,900 options to buy @ $4.82, valued at $129.7k
07/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Casdin Partners Master Fund, L.P. (10% Owner) has filed a Form 4 on MAXCYTE, INC.
Txns: Sold 3,235,548 shares @ $4.3, valued at $13.9M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy